Standard comparison card for assisting in interpreting KI67 proliferation index
Patent Information
- Authority / Receiving Office
- CN Β· China
- Current Assignee / Owner
- FOURTH HOSPITAL OF HEBEI MEDICAL UNIV
- Publication Date
- 2020-07-14
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of immunohistochemical detection. Background technique
[0002] KI67 is a non-histone nuclear cortex protein that is expressed in the nucleus in the G1, S, G2 and M phases of the cell cycle, but not in the G0 phase (the quiescent state of the cell). Therefore, the proportion of cells expressing KI67 in tumor cells (also called "KI67 proliferation index") can reflect the proportion of dividing cells in tumor cells, and is often used to judge the malignancy of tumors. The higher the KI67 proliferation index, usually The higher the degree of malignancy.
[0003] The KI67 proliferation index has emerged as a predictive and prognostic factor for breast cancer (BC). According to St. Gallen's guidelines, high proliferation KI67 is one of the characteristics of an increased risk of recurrence in estrogen receptor (ER)-positive HER2-negative BC, indirectly supporting the value of adding chemotherapy to endocrine therapy in t...